Vaccines Against Swine Respiratory Diseases
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Veterinary Vaccines".
Deadline for manuscript submissions: 31 May 2026 | Viewed by 8
Special Issue Editor
Interests: swine viral diseases; along with their immunology and vaccinology
Special Issue Information
Dear Colleagues,
Porcine respiratory disease complex (PRDC) is a multifaceted illness caused by a mix of viral and bacterial pathogens, environmental conditions, and management practices. Several key pathogens are associated with PRDC, including porcine circovirus 2 (PCV2), porcine reproductive and respiratory syndrome virus (PRRSV), and mycoplasma. Several other pathogens have been linked to PRDC, such as PCV3, PCV4, the swine influenza virus (SIV), porcine respiratory coronavirus (PRCV), porcine cytomegalovirus (PCMV), porcine parainfluenza virus 1 (PPIV1), and swine orthopneumovirus (SOV). With regard to bacteria, Actinobacillus pleuropneumoniae, Glasserella parasuis, and Bordetella bronchiseptica have been implicated.
Swine farming practices have evolved, resulting in a higher density, which has led to a higher prevalence of PRDC. In response, substantial efforts are being made to improve and develop new vaccine platforms. The goal of this Special Issue is to collate original research focused on the development and evaluation of vaccines for PRDC. We welcome the submission of original research articles and reviews. The research areas of interest include the following:
- Development and evaluation of current vaccines for managing infections associated with PRDC;
- Assessment of the immune response, including both innate and adaptive components, provided by existing and newly proposed vaccines for PRDC.
I look forward to receiving your contributions.
Prof. Dr. Jairo Jaime
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- porcine respiratory disease complex (PRDC)
- vaccines
- innate and adaptive immunity
- viruses
- bacteria
- adjuvants
- new vaccination strategies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
